News Performance of calprotectin and cystatin C in prediction of severe events in COVID-19 patients We at Gentian AS believe it is the duty of all companies in the health industry to help combat the…Super UserApril 27, 2020
News Immunomic Therapeutics Announces Close of $61.3M Financing – Bloomberg Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today the…Super UserApril 27, 2020
News 5 trends in venture capital (beyond the pandemic) | MIT Sloan Even prior to COVID-19, change was afoot in the venture capital industry. Machine learning and algorithms were emerging as new…Super UserApril 26, 2020
News How to reopen the US, according to Johns Hopkins and Harvard – Business Insider Most Americans are still stuck at home, but a trio of reports, out from Harvard, Johns Hopkins, and former US…Super UserApril 26, 2020
News What Is Contact Tracing? How It Will Be Used for COVID-19 | Time In the coronavirus era, a host of epidemiological terms have entered common public use. There’s the now-ubiquitous “social distancing,” and…Super UserApril 26, 2020
News Xconomy: Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle Even as the novel coronavirus has derailed daily life and business operations, the life sciences sector continues to see companies…Super UserApril 26, 2020
News JLABS @ Washington, DC Children’s QuickFire Challenge When a child gets seriously sick, it's up to us to fight for the world that they believe in. Johnson…Super UserApril 26, 2020
News Maryland’s venture capital funding was on the rise in Q1 2020. Then the pandemic arrived – Technical.ly Baltimore Maryland tech companies started the year bringing in a surge of venture capital funding, and three of the state’s top…Super UserApril 26, 2020
News What to do after receiving a Paycheck Protection Program loan – Philadelphia Business Journal Just over three weeks ago the CARES Act, a massive piece of legislation designed to combat the economic havoc being…Super UserApril 26, 2020
News REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD | REGENXBIO Inc. REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy…Super UserApril 26, 2020